1. Home
  2. LEXX vs NBY Comparison

LEXX vs NBY Comparison

Compare LEXX & NBY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LEXX
  • NBY
  • Stock Information
  • Founded
  • LEXX 2004
  • NBY 2000
  • Country
  • LEXX Canada
  • NBY United States
  • Employees
  • LEXX N/A
  • NBY N/A
  • Industry
  • LEXX Biotechnology: Pharmaceutical Preparations
  • NBY
  • Sector
  • LEXX Health Care
  • NBY
  • Exchange
  • LEXX Nasdaq
  • NBY Nasdaq
  • Market Cap
  • LEXX 16.5M
  • NBY 15.7M
  • IPO Year
  • LEXX N/A
  • NBY 2007
  • Fundamental
  • Price
  • LEXX $1.30
  • NBY $2.74
  • Analyst Decision
  • LEXX Strong Buy
  • NBY Strong Buy
  • Analyst Count
  • LEXX 1
  • NBY 1
  • Target Price
  • LEXX $4.00
  • NBY $0.85
  • AVG Volume (30 Days)
  • LEXX 193.3K
  • NBY 21.4M
  • Earning Date
  • LEXX 07-14-2025
  • NBY 11-06-2025
  • Dividend Yield
  • LEXX N/A
  • NBY N/A
  • EPS Growth
  • LEXX N/A
  • NBY N/A
  • EPS
  • LEXX N/A
  • NBY 0.41
  • Revenue
  • LEXX $615,923.00
  • NBY $9,781,000.00
  • Revenue This Year
  • LEXX $46.98
  • NBY $23.91
  • Revenue Next Year
  • LEXX $17.26
  • NBY $32.05
  • P/E Ratio
  • LEXX N/A
  • NBY $8.11
  • Revenue Growth
  • LEXX 49.85
  • NBY 113.47
  • 52 Week Low
  • LEXX $0.77
  • NBY $0.46
  • 52 Week High
  • LEXX $3.47
  • NBY $4.44
  • Technical
  • Relative Strength Index (RSI)
  • LEXX 76.03
  • NBY 60.21
  • Support Level
  • LEXX $0.98
  • NBY $2.28
  • Resistance Level
  • LEXX $1.34
  • NBY $3.12
  • Average True Range (ATR)
  • LEXX 0.09
  • NBY 0.63
  • MACD
  • LEXX 0.04
  • NBY 0.02
  • Stochastic Oscillator
  • LEXX 91.72
  • NBY 52.34

About LEXX Lexaria Bioscience Corp.

Lexaria Bioscience Corp's patented drug delivery technology, DehydraTECH improves the way active pharmaceutical ingredients enter the bloodstream by promoting more effective oral delivery. DehydraTECH can increase bio-absorption with cannabinoids and nicotine by 5-10x and, in some instances with cannabinoids by as much as 27x compared to standard industry formulations, reduce the time of onset from 1-2 hours to minutes, and mask unwanted tastes. DehydraTECH has also evidenced an ability to deliver some drugs more effectively across the blood-brain barrier. The company has four reportable segments: Intellectual Property Licensing which generates maximum revenue, B2B Production, Research and Development, and Corporate. Geographically, it derives revenue from the United States and Canada.

About NBY NovaBay Pharmaceuticals Inc.

NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops and sells scientifically-created and clinically-proven eyecare, wound care, and skin care products. Its product, Avenova Antimicrobial Lid and Lash Solution (Avenova Spray), is laboratory tested to have broad antimicrobial properties as it removes foreign material, including microorganisms and debris from the skin around the eye, including the eyelid. Avenova Spray is available directly to consumers through online distribution channels and is also often prescribed and dispensed by eyecare professionals for blepharitis and dry-eye disease.

Share on Social Networks: